CABG Based on CT-FFR Versus Conventional Coronary Angiography
NCT ID: NCT06028165
Last Updated: 2024-07-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
96 participants
INTERVENTIONAL
2023-10-20
2025-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Graft Patency After FFR-guided Versus Angio-guided CABG (GRAFFITI) Trial
NCT01810224
Impact of Preoperative FFR on Arterial Bypass Graft Functionality
NCT02527044
CT-angiographic Follow up of Patients That Underwent Coronary Bypass Surgery Between 1993-1997
NCT01686100
Graft Failure and Consequences of Coronary Artery Bypass Graft Surgery
NCT06800430
Graft Patency of QFR-guided Versus Angio-guided Coronary Artery Bypass Grafting
NCT03770520
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary end point is to evaluate early and 1-year postoperative graft patency. The secondary end points are overall survival, freedom from cardiac death and freedom from MACCE(major adverse cardiac or cerebrovascular events).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CAG group
Patients who underwent coronary artery bypass grafting based on conventional coronary angiography (quantitative coronary angiography)
Coronary artery bypass grafting based on conventional coronary angiography
Revascularized coronary arteries are decided based on conventional coronary angiography (quantitative coronary angiography)
CT-FFR group
Patients who underwent coronary artery bypass grafting based on cardiac computed tomography-derived fractional flow reserve
Coronary artery bypass grafting based on cardiac computed tomography-derived fractional flow reserve.
Revascularized coronary arteries are decided based on cardiac computed tomography-derived fractional flow reserve.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coronary artery bypass grafting based on conventional coronary angiography
Revascularized coronary arteries are decided based on conventional coronary angiography (quantitative coronary angiography)
Coronary artery bypass grafting based on cardiac computed tomography-derived fractional flow reserve.
Revascularized coronary arteries are decided based on cardiac computed tomography-derived fractional flow reserve.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age equal or less than 80
* patients who undergo coronary artery bypass grafting due to multi-vessel coronary artery disease
* patients who agree to the enrollment
Exclusion Criteria
* patients who have intractable ventricular arrhythmia
* patients who has been treated for cancer
* patients who has infectious disease
* patients who are planned to undergo combined cardiac surgery
* patients who has medical co-morbidity with expected survival less than 1 year
* patients with a history of previous cardiac surgery
* Patients with chronic renal failure requiring dialysis
* patients who undergo emergency operation
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Myongji Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Min-Seok Kim
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Min-Seok Kim, MD, PhD, MSc
Role: STUDY_CHAIR
Cardiovascular Center, Myongji Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Myongji Hospital
Goyang-si, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Min-Seok Kim, MD, PhD, MSc
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MyongjiH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.